Advertisement
Screener

EIDOS THERAPEUTICS, INC. Operating Income

EIDOS THERAPEUTICS, INC. Operating Income

EIDOS THERAPEUTICS, INC. reported Operating Income of -$29.40 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2020-10-29

  • EIDOS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-09-30 was -$29.40M, a 570.37% decline year-over-year.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-06-30 was -$28.24M.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-03-31 was -$22.89M.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-12-31 was -$19.32M.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for fiscal 2019 was -$40.45M.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for fiscal 2018 was -$37.78M.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for fiscal 2017 was -$12.02M.
  • EIDOS THERAPEUTICS, INC. operating income (loss) for fiscal 2016 was -$2.38M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 month
2020-09-30-$29.40M
10-Q · filed 2020-10-29
-$57.64M
derived: sum of 2 quarters · filed 2020-10-29
-$80.53M
10-Q · filed 2020-10-29
-$99.85M
derived: sum of 4 quarters · filed 2020-10-29
2020-06-30-$28.24M
10-Q · filed 2020-08-06
-$51.13M
10-Q · filed 2020-08-06
-$70.45M
derived: sum of 3 quarters · filed 2020-08-06
-$64.20M
derived: sum of 4 quarters · filed 2020-10-29
2020-03-31-$22.89M
10-Q · filed 2020-05-08
-$42.21M
derived: sum of 2 quarters · filed 2020-05-08
-$35.96M
derived: sum of 3 quarters · filed 2020-10-29
-$50.75M
derived: sum of 4 quarters · filed 2020-10-29
2019-12-31-$19.32M
10-K · filed 2020-02-26
-$13.07M
derived: sum of 2 quarters · filed 2020-10-29
-$27.87M
derived: sum of 3 quarters · filed 2020-10-29
-$40.45M
10-K · filed 2020-02-26
2019-09-30$6.25M
10-Q · filed 2020-10-29
-$8.54M
derived: sum of 2 quarters · filed 2020-10-29
-$21.13M
10-Q · filed 2020-10-29
-$31.83M
derived: sum of 4 quarters · filed 2020-10-29
2019-06-30-$14.79M
10-Q · filed 2020-08-06
-$27.38M
10-Q · filed 2020-08-06
-$38.08M
derived: sum of 3 quarters · filed 2020-08-06
-$49.07M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$12.58M
10-Q · filed 2020-05-08
-$23.29M
derived: sum of 2 quarters · filed 2020-05-08
-$34.28M
derived: sum of 3 quarters · filed 2020-05-08
-$42.37M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31-$10.71M
10-K · filed 2020-02-26
-$21.69M
derived: sum of 2 quarters · filed 2020-02-26
-$29.78M
derived: sum of 3 quarters · filed 2020-02-26
-$37.78M
10-K · filed 2020-02-26
2018-09-30-$10.99M
10-K · filed 2020-02-26
-$10.55M
10-Q · filed 2018-11-06
-$19.08M
derived: sum of 2 quarters · filed 2020-02-26
-$27.07M
10-Q · filed 2019-10-31
-$28.02M
10-Q · filed 2018-11-06
-$32.19M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$8.09M
10-K · filed 2020-02-26
-$9.29M
10-Q · filed 2018-08-07
-$16.09M
10-Q · filed 2019-08-01
-$17.47M
10-Q · filed 2018-08-07
-$21.20M
derived: sum of 3 quarters · filed 2020-02-26
-$23.97M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$8.00M
10-K · filed 2020-02-26
-$13.11M
derived: sum of 2 quarters · filed 2020-02-26
-$15.88M
derived: sum of 3 quarters · filed 2020-02-26
-$17.60M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$5.11M
10-K · filed 2019-04-15
-$7.88M
derived: sum of 2 quarters · filed 2019-04-15
-$9.60M
derived: sum of 3 quarters · filed 2019-04-15
-$12.02M
10-K · filed 2020-02-26
2017-09-30-$2.77M
10-K · filed 2019-04-15
-$4.49M
derived: sum of 2 quarters · filed 2019-04-15
-$6.91M
10-Q · filed 2018-11-06
2017-06-30-$1.72M
10-K · filed 2019-04-15
-$4.13M
10-Q · filed 2018-08-07
2017-03-31-$2.42M
10-K · filed 2019-04-15
2016-12-31-$2.38M
10-K · filed 2019-04-15